Paul Noone

2.5k citations
71 papers · 1.9k · h-index 22

Impact in

Papers in

    • Antibiotics Pharmacokinetics and Efficacy 28
    • Antimicrobial Resistance in Staphylococcus 11
    • Clostridium difficile and Clostridium perfringens research 4
    • Antifungal resistance and susceptibility 4

Paul Noone

67 papers receiving 1.7k citations

Peers

Paul Noone
Comparison fields: 5 of 113
  • Molecular Medicine 264
  • Clinical Biochemistry 221
  • Applied Microbiology and Biotechnology 61
  • Infectious Diseases 570
  • Pharmacology 460
Replace Wendell H. Hall with:
Wendell H. Hall United States
F. O’Grady United Kingdom
Joyce A. Korvick United States
E. J. C. Goldstein United States
H. Gaya United Kingdom
L Kager Sweden
A.‐S. Malmborg Sweden
D. W. Burdon United Kingdom
Lennart Nilsson Sweden
Éric Batard France
Paul Noone relative to Wendell H. Hall United States Wendell H. Hall's profile →
Citations per field
00.5×
Wendell H. Hall · 1×
Citations per year

Countries citing papers authored by Paul Noone

Since Specialization
Citations

This map shows the geographic impact of Paul Noone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Noone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Noone more than expected).

Fields of papers citing papers by Paul Noone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Noone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Noone. The network helps show where Paul Noone may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Noone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Noone Line = papers co-authored together Paul Noone links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1974285
2 1984169
3 1974136
4 1982126
5 1977106
6 198578
7 198075
8 198357
9 198052
10 197152
11 197752
12 198150
13 198844
14 198642
15 198940
16 197136
17 197436
18
The effective use of gentamicin in life-threatening sepsis.
197435
19 197634
20 200526

About Paul Noone

Paul Noone is a scholar working on Pharmacology, Infectious Diseases, Molecular Medicine, Epidemiology and Clinical Biochemistry, having authored 71 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial Identification and Susceptibility Testing (11 papers), Neutropenia and Cancer Infections (6 papers), Mycobacterium research and diagnosis (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Antifungal resistance and susceptibility (4 papers). The work is most often cited by research in Molecular Medicine (264 citations), Clinical Biochemistry (221 citations), Applied Microbiology and Biotechnology (61 citations), Infectious Diseases (570 citations) and Pharmacology (460 citations). Paul Noone has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include J Pattison, Richard Slack, R E Pounder, Andrew Kirk, W.B. Grubb, Penny Smith, Andrew K. Burroughs, Elizabeth C. Wood, R P Walt and Marina Alessandra Pereira. Their work appears in journals such as The Lancet, Journal of Antimicrobial Chemotherapy, Journal of Clinical Pathology, Journal of Infection and Archives of Disease in Childhood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact